José Antonio
Calera Abad
Profesor Titular de Universidad
XOSE R.
GARCIA BUSTELO
Investigador
Publications dans lesquelles il/elle collabore avec XOSE R. GARCIA BUSTELO (15)
2023
-
Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors
Oncogene, Vol. 42, Núm. 5, pp. 389-405
2022
-
A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors
Cell Reports, Vol. 38, Núm. 11
-
Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model
Molecular Oncology, Vol. 16, Núm. 19, pp. 3533-3553
-
Hematopoietic Cells Influence Vascular Development in the Retina
Cells, Vol. 11, Núm. 20
-
The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function
Oncogene, Vol. 41, Núm. 24, pp. 3341-3354
2021
-
Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis
EMBO Journal, Vol. 40, Núm. 22
-
Distinct roles of vav family members in adaptive and innate immune models of arthritis
Biomedicines, Vol. 9, Núm. 6
2020
-
VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma
Nature Communications, Vol. 11, Núm. 1
-
Vav2 catalysis-dependent pathways contribute to skeletal muscle growth and metabolic homeostasis
Nature Communications, Vol. 11, Núm. 1
-
Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor
Oncogene, Vol. 39, Núm. 28, pp. 5098-5111
2019
-
Vagal afferents contribute to sympathoexcitation-driven metabolic dysfunctions
Journal of Endocrinology, Vol. 240, Núm. 3, pp. 483-496
2017
-
A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia
Cancer Cell, Vol. 32, Núm. 5, pp. 608-623.e9
2013
2012
-
The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development
Molecular Biology of the Cell, Vol. 23, Núm. 12, pp. 2373-2387
2011
-
Transcriptional factor Aryl hydrocarbon receptor (Ahr) controls cardiovascular and respiratory functions by regulating the expression of the Vav3 proto-oncogene
Journal of Biological Chemistry, Vol. 286, Núm. 4, pp. 2896-2909